FDA.reportPublic FDA data

24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG Extended Release Oral Capsule [Namzaric]

RxCUI
1602588
RxNorm name
24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG Extended Release Oral Capsule [Namzaric]
Display name
24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG Extended Release Oral Capsule [Namzaric]
Full name
24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG Extended Release Oral Capsule [Namzaric]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NamzaricMEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDEAllergan, Inc.90fedc32-19e5-480c-afc6-f35a5cf4b9aa2026-03-06Warnings, Adverse reactionsExact identifier
rxcui: 1602588

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
90fedc32-19e5-480c-afc6-f35a5cf4b9aaNamzaric 14 MG / 10 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG Extended Release Oral Capsule [Namzaric] [SBD] · Namzaric (donepezil HCl 10 MG / memantine HCl 14 MG) 24 HR Extended Release Oral Capsule [SY]323These highlights do not include all the information needed to use NAMZARIC capsules safely and effectively. See full prescribing information for NAMZARIC capsules. NAMZARIC (memantine and donepezil hydrochlorides) extended-release capsules, for oral use Initial U.S. Approval: 201420260306